Beyond its role in tumor profiling, ctDNA has demonstrated promise in detecting disease recurrence and minimal residual disease with greater specificity and sensitivity than conventional markers, such as CA125 or CT imaging. The gene discussed is MUC16; the disease is neoplasm.